CALITHERA BIOSCIENCES (CALA) Covered Calls

CALITHERA BIOSCIENCES covered calls Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.

You can sell covered calls on CALITHERA BIOSCIENCES to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CALA (prices last updated Fri 4:16 PM ET):

CALITHERA BIOSCIENCES (CALA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
5.21 -0.28 4.30 5.15 480K - 0.2B
Covered Calls For CALITHERA BIOSCIENCES (CALA)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 5 0.25 4.90 2.0% 25.2%
Dec 21 5 0.70 4.45 12.4% 70.7%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Calithera Biosciences, Inc. is a clinical-stage pharmaceutical company, which focuses on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. Its clinical candidate, CB-839, blocks glutaminase, an enzyme critical to tumor metabolism, and is currently being tested in patients with advanced solid and hematological cancers. The company was founded by James A. Wells and Susan M. Molineaux in March 9, 2010 and is headquartered in South San Francisco, CA.